Remicure Life Sciences Private Limited
About Remicure Life Sciences Private Limited
Data last updated:
Remicure Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 06 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2016PTC110734. Its GSTIN is 36AAHCR8899J1ZD (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Roshan Pulla and Rangareddy Kuntarangayola.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. F25/B Phase 1 I.D.A Jeedimetla, Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.23 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.42 Lakh (net margin -22.8%) and EBITDA of -₹1.41 Lakh (EBITDA margin -22.6%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 25% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Remicure Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No. F25/B Phase 1 I.D.A Jeedimetla, Hyderabad, Telangana, India – 500055
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Remicure Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Remicure Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Remicure Life Sciences Private Limited, buy the company report.
Financials of Remicure Life Sciences Private Limited
FY 2025 filings availableRemicure Life Sciences Private Limited reported revenue of ₹6.23 Lakh (up 441% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 441% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 25%. EBITDA fell 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.42 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -22.6% | ||||
| Net Profit Margin | -22.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Remicure Life Sciences Private Limited, buy the company report.
Board of directors of Remicure Life Sciences Private Limited
Remicure Life Sciences has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rangareddy Kuntarangayola | Additional Director | 27 Apr 2024 | 2 Years 5 Months | Current |
| Roshan Pulla | Director | 06 Jul 2016 | 10 Years 3 Months | Current |
Peer comparison
Remicure Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Midde's Lifesciences Private Limited | ₹6.23 Lakh (FY 2022) | 703.0% | Hyderabad, Telangana, India | |||
| Urpan Creation Private Limited | ₹6.23 Lakh (FY 2019) | -84.0% | Kolkata, West Bengal, India | |||
| Tapan Solar Energy Private Limited | ₹6.23 Lakh (FY 2024) | 194.0% | Delhi, India | |||
| Candile Engineering Solutions Private Limited | ₹6.23 Lakh (FY 2024) | Ernakulam, Kerala, India | ||||
| Concoct Engineering System Private Limited | ₹6.23 Lakh (FY 2020) | 129.0% | New Delhi, Delhi, India | |||
| Remicure Life Sciences Private Limitedthis company | ₹6.23 Lakh (FY 2024) | -₹1.42 Lakh | -22.8% | 441.0% | Hyderabad, Telangana, India | |
| Sfed India Private Limited | ₹6.23 Lakh (FY 2021) | Gurugram, Haryana, India | ||||
| Parampariya Nattu Marundhu Urpathiyalargal Producer Company Limited | ₹6.23 Lakh (FY 2022) | -55.0% | Virudhunagar, Tamil Nadu, India | |||
| SP I-Cannano Research Private Limited | ₹6.23 Lakh (FY 2017) | 15.0% | Mumbai, Maharashtra, India | |||
| JKD Consultancy & Services Private Limited | ₹6.22 Lakh (FY 2025) | 71.0% | Patna, Bihar, India | |||
| Z Speed Pharma Private Limited | ₹6.22 Lakh (FY 2025) | -32.0% | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of Remicure Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Remicure Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Remicure Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Remicure Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCR8899J1ZD | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Remicure Life Sciences Private Limited, buy the company report.
Recent activity
Remicure Life Sciences Private Limited has 11 board changes on record since 2016: 3 appointments and 8 cessations. The latest: Abhishek Manepalli ceased to be Additional Director on 04 Jun 2025.
2 earlier events are in the company report.
Frequently asked questions
Remicure Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 06 July 2016 (10+ years old) and is registered under CIN U74999TG2016PTC110734.
Remicure Life Sciences has 2 current directors:
- Rangareddy Kuntarangayola - Additional Director
- Roshan Pulla - Director
The latest financial statements of Remicure Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Remicure Life Sciences is 36AAHCR8899J1ZD, registered in Telangana.
The CIN (Corporate Identification Number) of Remicure Life Sciences is U74999TG2016PTC110734. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Remicure Life Sciences was incorporated on 06 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Remicure Life Sciences by revenue are Midde's Lifesciences Private Limited, Urpan Creation Private Limited, Tapan Solar Energy Private Limited, Candile Engineering Solutions Private Limited, Concoct Engineering System Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Abhishek Manepalli ceased to be Additional Director on 04 Jun 2025. Pappala Naveen ceased to be Additional Director on 04 Jun 2025. Pulla Rahul ceased to be Additional Director on 04 Jun 2025. Remicure Life Sciences has 11 board changes on record in total.
The registered office of Remicure Life Sciences is at Flat No. F25B Phase 1 I.D.A Jeedimetla, Hyderabad, Telangana, India – 500055.
Remicure Life Sciences operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Remicure Life Sciences is compliant as of 27 August 2026. The company is actively filing with the Registrar of Companies.